The improved prediction of CAD severity and incidence in SMuRFless patients is suggestive that the mechanism that results in the elevation of sLOX-1 may be even more of an important moderator of risk than in those whose disease is driven by traditional risk factors. Here, OLR1 is linked to coronary artery disorder.